Trials that use: Multiple imputation / missing data
New to this method? Read the tutorial →
20,324 results
- GRC00097Independent statistical analysis of Collection of Serum Samples From Children and Older Adults Receiving the 2019-2020 Formulations of Fluzone® Quadrivalent and Fluzone® High-Dose Influenza Vaccines, Respectively: primary endpoint results, effect estimate with…
- GReaTIndependent statistical analysis of Gene Regulation by Thiazolidinediones: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00567593).
- GREATIndependent statistical analysis of Get Ready And Empowered About Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02165735).
- Greater Occipital and Supraorbital Nerve Blockade in Migraine Patients: Complete Statistical AnalysisIndependent statistical analysis of Greater Occipital and Supraorbital Nerve Blockade in Migraine Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03435185).
- Greater Occipital Nerve Block Versus Metoclopramide: Complete Statistical AnalysisIndependent statistical analysis of Greater Occipital Nerve Block Versus Metoclopramide: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03269435).
- GRECOIndependent statistical analysis of Study to Assess Functionality, Reliability, and Performance of a Single-Use Auto-Injector With Benralizumab Administered at Home: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- GRECO-1Independent statistical analysis of Phase I/II Study of SBRT and GC4711 for Centrally Located or Large NSCLC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Green Tea and Reduction of Breast Cancer Risk: Complete Statistical AnalysisIndependent statistical analysis of Green Tea and Reduction of Breast Cancer Risk: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00917735).
- Green Tea, Black Tea, or Water in Treating Patients With Prostate Cancer Undergoing Surgery: Complete Statistical AnalysisIndependent statistical analysis of Green Tea, Black Tea, or Water in Treating Patients With Prostate Cancer Undergoing Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- GreenLight XPS Laser System Retrospective Chart Review: Complete Statistical AnalysisIndependent statistical analysis of GreenLight XPS Laser System Retrospective Chart Review: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02139969).
- GRIDIndependent statistical analysis of Study of Regorafenib as a 3rd-line or Beyond Treatment for Gastrointestinal Stromal Tumors (GIST): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- GRINIndependent statistical analysis of Testing Preliminary Effectiveness of a Training to Support CHWs Outreach on Dental to African American Caregivers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- GRIPHONIndependent statistical analysis of the GRIPHON phase 3 trial of selexipag in pulmonary arterial hypertension, covering its randomized time-to-event endpoint, secondary analyses, statistical methods, confidence intervals, and interpretation.
- GROIndependent statistical analysis of Effect of Infant Formula on Energy Balance: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01700205).
- Group Antenatal Care: Effectiveness and Contextual Factors Linked to Implementation Success in Malawi: Complete Statistical AnalysisIndependent statistical analysis of Group Antenatal Care: Effectiveness and Contextual Factors Linked to Implementation Success in Malawi: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Group-Based Intervention to Improve Mental Health and Adherence Among Youth Living With HIV in Low Resource Settings: Complete Statistical AnalysisIndependent statistical analysis of Group-Based Intervention to Improve Mental Health and Adherence Among Youth Living With HIV in Low Resource Settings: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Growth Hormone and GnRH Agonist in Adolescents With Acquired Hypothyroidism: Complete Statistical AnalysisIndependent statistical analysis of Growth Hormone and GnRH Agonist in Adolescents With Acquired Hypothyroidism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00206375).
- Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance: Complete Statistical AnalysisIndependent statistical analysis of Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Growth Hormone Treatment in Children With Phelan McDermid Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Growth Hormone Treatment in Children With Phelan McDermid Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04003207).
- Growth Hormone Treatment in Patients With Aggrecan (ACAN) Deficiency: Complete Statistical AnalysisIndependent statistical analysis of Growth Hormone Treatment in Patients With Aggrecan (ACAN) Deficiency: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03288103).
- Growth-TBIIndependent statistical analysis of Recombinant Human Growth Hormone During Rehabilitation From Traumatic Brain Injury.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00766038).
- GS2Independent statistical analysis of A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease: primary endpoint results, effect estimate with confidence interval, sample-size…
- GSK1120212 vs Chemotherapy in Advanced or Metastatic BRAF V600E/K Mutation-positive Melanoma: Complete Statistical AnalysisIndependent statistical analysis of GSK1120212 vs Chemotherapy in Advanced or Metastatic BRAF V600E/K Mutation-positive Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- GSK1120212+GSK2141795 for Cervical Cancer: Complete Statistical AnalysisIndependent statistical analysis of GSK1120212+GSK2141795 for Cervical Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01958112).
- GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection: Complete Statistical AnalysisIndependent statistical analysis of GSK1322322 Versus Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- GSK1550188 A 52 Week Study of Belimumab Versus Placebo in the Treatment of Subjects With Systemic Lupus Erythematosus (SLE) Located in Northeast Asia: Complete Statistical AnalysisIndependent statistical analysis of GSK1550188 A 52 Week Study of Belimumab Versus Placebo in the Treatment of Subjects With Systemic Lupus Erythematosus (SLE) Located in Northeast Asia: primary endpoint results, effect estimate…
- GSK2251052 in the Treatment of Complicated Intra-abdominal Infections: Complete Statistical AnalysisIndependent statistical analysis of GSK2251052 in the Treatment of Complicated Intra-abdominal Infections: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01381562).
- GSK3174998 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors (ENGAGE-1): Complete Statistical AnalysisIndependent statistical analysis of GSK3174998 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors (ENGAGE-1): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- GSK573719 Dose Ranging Study in Chronic Obstructive Pulmonary Disease: Complete Statistical AnalysisIndependent statistical analysis of GSK573719 Dose Ranging Study in Chronic Obstructive Pulmonary Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00950807).
- GSP 301-305Independent statistical analysis of Efficacy and Safety of GSP 301 Nasal Spray in Children (Aged 6 to Under 12 Years) With Seasonal Allergic Rhinitis (SAR): primary endpoint results, effect estimate with confidence…
- GTRDOXYIndependent statistical analysis of Effect of Postsurgical Systemic Doxycycline After Regenerative Periodontal Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01030666).
- GTx-758 on Serum Prostate-specific Antigen (PSA) in Men With Castrate Resistant Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of GTx-758 on Serum Prostate-specific Antigen (PSA) in Men With Castrate Resistant Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Guanfacine to Reduce Relapse Risk in Women With Alcohol Use Disorder (AUD): Complete Statistical AnalysisIndependent statistical analysis of Guanfacine to Reduce Relapse Risk in Women With Alcohol Use Disorder (AUD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- guardian™ 3Independent statistical analysis of Safety and Efficacy of Turoctocog Alfa in Previously Treated Male Children With Haemophilia A: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- guardian™1Independent statistical analysis of Safety and Efficacy of Turoctocog Alfa in Haemophilia A Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00840086).
- GUIDEIndependent statistical analysis of Guidance of Ultrasound in Intensive Care to Direct Euvolemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03938038).
- GUIDE-ITIndependent statistical analysis of Guiding Evidence Based Therapy Using Biomarker Intensified Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01685840).
- GUIDEDIndependent statistical analysis of Genomics Used to Improve DEpression Decisions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02109939).
- GuidePathIndependent statistical analysis of Study of Diagnostic Performance of [18F]CTT1057 in BCR: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04838613).
- GUIDOR® Growth Factor Enhanced Bone Graft Substitute for the Treatment of Periodontal Defects 6-months Post-Surgery: Complete Statistical AnalysisIndependent statistical analysis of GUIDOR® Growth Factor Enhanced Bone Graft Substitute for the Treatment of Periodontal Defects 6-months Post-Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Gulf War Digestive Health Study: Complete Statistical AnalysisIndependent statistical analysis of Gulf War Digestive Health Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00680836).
- Guselkumab in the Treatment of Pityriasis Rubra Pilaris (PRP): Complete Statistical AnalysisIndependent statistical analysis of Guselkumab in the Treatment of Pityriasis Rubra Pilaris (PRP): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03975153).
- gustinpropIndependent statistical analysis of Gustin Gene Polymorphism and 6-n-propylthiouracil (PROP) Taste: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01097915).
- Gut Decontamination In Pediatric Allogeneic Hematopoietic: Complete Statistical AnalysisIndependent statistical analysis of Gut Decontamination In Pediatric Allogeneic Hematopoietic: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02641236).
- Gut Microbiome & Gastrointestinal Toxicities as Determinants of Response to Neoadjuvant Chemo for Advanced Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Gut Microbiome & Gastrointestinal Toxicities as Determinants of Response to Neoadjuvant Chemo for Advanced Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Gut Organoid and Microbiome Interactions in Hypertension: Complete Statistical AnalysisIndependent statistical analysis of Gut Organoid and Microbiome Interactions in Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04497727).
- GVAX Pancreas Vaccine (With CY) in Combination With Nivolumab and SBRT for Patients With Borderline Resectable Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of GVAX Pancreas Vaccine (With CY) in Combination With Nivolumab and SBRT for Patients With Borderline Resectable Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- GVHD ASEDIndependent statistical analysis of A Randomized, Controlled, Double-Masked, Clinical Trial of Autologous Serum Eye Drops for Severe Ocular Chronic Graft-versus-Host Disease (GVHD) in Hematopoietic Stem Cell Transplant (HSCT) Patients: primary endpoint results,…
- GWIndependent statistical analysis of Neoadjuvant GW572016 to Treat Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00206427).
- GWIIRTIndependent statistical analysis of Gulf War Illness Inflammation Reduction Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02506192).